drugset / Trial / NCT00747721

Pharmacokinetics of Dexmedetomidine During Prolonged Infusion in ICU

NCT00747721

Phase 1 Completed 13 enrolled Orion Corporation, Orion Pharma
Non-randomizedSingle-groupOpen-labelBasic science

Summary

The study will examine dexmedetomidine levels in the blood of critically ill intensive care patients to understand how it is broken down by the body.

Timeline

Start
2008-09
Primary completion
2009-01
Completion
2009-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified Intravenous

Indications

No indication recorded.